Continuous versus interrupted suture technique for hepaticojejunostomy (HEKTIK trial)

Not Applicable

Recruiting

• Conditions: C25.0; C24; Head of pancreas; Malignant neoplasm of other and unspecified parts of biliary tract

• Registration Number: DRKS00024395
• Lead Sponsor: niversitätsklinikum Erlangen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Age = 18 years
• Indication for the elective performance of a hepaticojejunostomy
• Diameter of the common bile duct to be anastomosed = 5 mm (preoperative measurement in the imaging (CT or MRT))
• ASA I-III

Exclusion Criteria

• Performance of a hepaticojejunostomy as part of a liver resection or a liver transplantation
• Simultaneous arterial reconstruction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of early postoperative anastomotic leakage

Secondary Outcome Measures

Name	Time	Method
- Operative time<br>- Postoperative increase in cholestasis parameters (?GT, AP, bilirubin)<br>- re-operation rate<br>- re-intervention rate (ERCP, PTCD)<br>- Morbidity (within the hospital stay and after 3 months)<br>- Mortality (within the hospital stay and after 3 months)<br>- Time for the Performance of the hepaticojejunostomy<br>- Material costs for the hepaticojejunostomy